The ability to directly uncover the contributions of genes to a given phenotype is fundamental for biology research. However, ostensibly homogeneous cell populations exhibit large clonal variance 1,2 that can confound analyses and undermine reproducibility 3 . Here we used genome-saturated mutagenesis to create a biobank of over 100,000 individual haploid mouse embryonic stem (mES) cell lines targeting 16,970 genes with genetically barcoded, conditional and reversible mutations. This Haplobank is, to our knowledge, the largest resource of hemi/homozygous mutant mES cells to date and is available to all researchers. Reversible mutagenesis overcomes clonal variance by permitting functional annotation of the genome directly in sister cells. We use the Haplobank in reverse genetic screens to investigate the temporal resolution of essential genes in mES cells, and to identify novel genes that control sprouting angiogenesis and lineage specification of blood vessels. Furthermore, a genome-wide forward screen with Haplobank identified PLA2G16 as a host factor that is required for cytotoxicity by rhinoviruses, which cause the common cold. Therefore, clones from the Haplobank combined with the use of reversible technologies enable high-throughput, reproducible, functional annotation of the genome.
The ability to directly uncover the contributions of genes to a given phenotype is fundamental for biology research. However, ostensibly homogeneous cell populations exhibit large clonal variance 1,2 that can confound analyses and undermine reproducibility 3 . Here we used genome-saturated mutagenesis to create a biobank of over 100,000 individual haploid mouse embryonic stem (mES) cell lines targeting 16,970 genes with genetically barcoded, conditional and reversible mutations. This Haplobank is, to our knowledge, the largest resource of hemi/homozygous mutant mES cells to date and is available to all researchers. Reversible mutagenesis overcomes clonal variance by permitting functional annotation of the genome directly in sister cells. We use the Haplobank in reverse genetic screens to investigate the temporal resolution of essential genes in mES cells, and to identify novel genes that control sprouting angiogenesis and lineage specification of blood vessels. Furthermore, a genome-wide forward screen with Haplobank identified PLA2G16 as a host factor that is required for cytotoxicity by rhinoviruses, which cause the common cold. Therefore, clones from the Haplobank combined with the use of reversible technologies enable high-throughput, reproducible, functional annotation of the genome.
Approaches to functionally analyse the mammalian genome include ENU (N-ethyl-nitrosourea) mutagenesis 4 , gene targeting 5 , RNA interference 6,7 and CRISPR-mediated genome editing 8 . Although powerful, these approaches have various caveats, such as poor knockdown efficiency and off-target effects [9] [10] [11] . Additionally, clonal variability within populations can compromise comparisons and reproducibility 3, [12] [13] [14] . Therefore, reversible mutations that enable the direct comparison of phenotypes within a single clone are essential for the study of genetic dependencies.
To generate a conditional mutagenesis system at a genome-wide scale and at the clonal level, we applied insertional mutagenesis using genetically barcoded, lentivirus-based, retrovirus-based 15, 16 and transposonbased (Tol2 (ref. 17 and sleeping beauty (SB) 18 ) vectors in haploid mES cells (Fig. 1a) that enable recessive genetics. We analysed several parthenogenetic haploid mES cell lines (129/Sv and C57BL/6 background) (Extended Data Fig. 1a, b ) and chose to use AN3-12 cells, which grow in feeder-free conditions and maintain a stable haploid genome across many generations in an undifferentiated state. These cells express pluripotency markers and differentiate into all germ layers in vivo (Extended Data Fig. 1c-h ). Notably, AN3-12 cells display only minor genomic duplications and deletions that potentially affect the genes Cdh4, Taf4 (also known as Taf4a), Agmo and Cox7c (Extended Data Fig. 2 ). Insertional mutagenesis permits the integration of invertable splice acceptors, resulting in conditional alleles, as well as high-throughput direct identification of integration sites. To map insertion sites and complex internal barcodes (> 10 7 ) by inverse PCR, an optimized universal sequencing strategy was established (Extended Data Fig. 3a, b) . A combination of strategies was used to avoid genomic biases of the insertional mutagenesis systems ( (Fig. 1c) . Of note, Tol2 outperformed the classical viral delivery systems and even in silico mutagenesis at less than one million integrations (Fig. 1c) . The mutagenesis systems also generated antisense and intergenic integrations at a high frequency owing to cryptic transcriptional start sites (Extended Data Fig. 4b, c) , however, this is not expected to affect disruption of transcription in sense orientation. Therefore, we used various delivery systems to obtain unbiased, genome-saturated and conditional mutagenesis.
Next, we developed a high-throughput pipeline to create a biobank of reversible mutations in AN3-12 haploid mES cells. Starting from haploid mES cell pools that contained between 10 7 and 10 8 distinct mutations for each mutagen, we arrayed, processed, banked and mapped over 100,000 individual mES cell clones (Extended Data Fig. 4d-g ). In total, we generated sense and antisense clones that target 16,970 out of approximately 24,000 annotated mouse genes (genome release mm10), covering over 70% of the protein-coding genome (Extended Data Fig. 5a -c and Supplementary Table 1) . Integrations display a 5′ bias in genes and in the coding sequence (Extended Data Fig. 5d ), resulting in truncations that are likely to generate loss-offunction alleles. All pools of mutated cells are available at https:// www.haplobank.at. This resource represents a comprehensive library of mES cell clones carrying hemi/homozygous, twice reversible, barcoded integrations, combining the power of stem cells with tunable mutagenesis.
A key advantage of the Haplobank is the ability to compare each mES cell clone with its sister clone carrying the conditionally inverted splice acceptor. As a proof-of-principle, we analysed two mES cell clones containing sense integrations within Ctnna1, which encodes α -E-catenin and is essential for mES cell adhesion 21 . mES cells with sense integrations showed reduced Ctnna1 expression and impaired cell adhesion, which were both restored by FlpO-mediated reversal of the integrated mutagenesis vectors. Furthermore, Cre-mediated reversal back into the sense orientation again disrupted α -E-catenin-mediated cell adhesion (Fig. 1d, e) . Additionally, we evaluated mES cell lines carrying non-disruptive, antisense integrations in presumed essential genes. We infected these mES cell lines with a pool of retroviruses that encode Cre and mCherry, or GFP only. If a gene is essential, Cre-mediated reversion of the integration to the disruptive sense orientation should specifically deplete mCherry + cells from the mCherry + GFP + cell pool over time, as detected by flow cytometry. We confirmed the essential role of several genes for mES cell survival (Fig. 2a, b) . Therefore, our system enables direct, functional annotation of gene essentiality, instead of screening for the absence of mutations; moreover, one can directly examine the penetrance and timing of lethal phenotypes. In silico Splice acceptor sites (SA) are reversible using non-compatible loxP/lox5171 and FRT/F3 sites (triangles). G418 resistance is conferred by β -Geo (bgeo) transcribed from the reversible cassette (gene-trap vectors, GT) or Neo independently from a PGK promoter (polyA trap), stabilized by a splice donor (SD). Six osteopontin-enhancer (OPE) elements (enhanced gene trap; Lenti-ETG, Retro-EGT, and Tol2-EGT vectors) enhance expression of β -Geo through Oct4 (also known as Pou5f1) binding. RetroRS carries a spacer sequence between loxP sites and lacks OPEs. Purple diamonds indicate internal barcodes (BC). LTR, long terminal repeats; L200/R175 and LITR/RITR, terminal repeats of Tol2 and SB. b, Heat map representing numbers of integrations per gene per one million integrations. Gene expression levels (left column) are shown (blue, highly expressed; white, not expressed). Colour code (remaining columns) shows the numbers of integrations per one million integrations. c, Saturation of mutagenesis systems compared to random in silico mutagenesis. y axis, total numbers of insertions versus the percentage of genes with integrations. d, Schematic representation of splice acceptor inversions. e, Loss of mES cell adhesion in clones with integrations in intron 1 of Ctnna1. Inversion of the gene trap restores cell adhesion, subsequent reversion again disruptes adhesion. Phalloidin is used to visualize polymerized actin; DAPI visualizes nuclei. Scale bars, 10 μ m. One representative experiment out of two biological replicates is shown. + cells. c, Integration sites of top scoring genes in our haploid mES cell survival screen of human rhinovirus RV-A1a infections. Loss-of-function score for integrations into the Ldlr locus P = 2.9 × 10 −12 and P = 1.4 × 10 −11 for Pla2g16. Sense integrations, red triangles; antisense integrations, green triangles; exons, blue boxes. Transcriptional start sites are marked. d, Growth advantage of sense versus respective antisense sister mES cells with integrations in Pla2g16 or Ldlr upon infection with RV-A1a. In uninfected cells, mutation of these genes did not confer growth advantages; arbitrarily set to one. e, HEK293T cells were transduced with four different sgRNAs against PLA2G16 and LDLR in biological triplicates, mixed with control GFP + HEK293T cells at a ratio of 1:3. Ratios of control to mutated HEK293T cells were evaluated on day 13 after infection using FACS. Data are mean ± s.d. (d, e) with individual data points (diamonds) normalized to uninfected cells. * P < 0.05, * * P < 0.01, * * * P < 0.001; one-tailed Student's t-test. f, Targeting of the C-terminus of mouse Pla2g16 using CRISPRCas9. Upon selection of haploid cells to ensure hemizygous editing, cells were split and maintained in the presence and absence of RV-A1a.
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We subsequently performed a genome-wide screen to uncover novel hits for resistance against infection with a common cold virus. We chose the rhinovirus serotype RV-A1a, which replicates in mouse cells 22 . A pool of mES cells carrying gene-trap insertions was exposed to rhinovirus every other day for three weeks. The surviving, virusresistant cells displayed an enrichment for multiple disruptive insertions in the low-density lipoprotein receptor (Ldlr), a known entry portal for this virus (P = 2.9 × 10 −12 ), and in the phospholipase Pla2g16 (P = 1.4 × 10 −11 ) (Fig. 2c) . We confirmed that these genes are required for killing of the virus using three different sister clones with reversible integrations (Fig. 2d) . Next, we used CRISPR-Cas9 technology to disrupt these genes in human embryonic kidney (HEK293T) cells and monitored competitive proliferation with and without RV-A1a infection. In this assay, LDLR was not required for RV-A1a-mediated killing (Fig. 2e) , presumably because the virus can enter via other receptors in the absence of functional LDLR in HEK293T cells 23 . Notably, we confirmed that inactivation of PLA2G16 with different single-guide RNAs (sgRNAs) confers a selective survival advantage to HEK293T cells exposed to RV-A1a (Fig. 2e) . Therefore, the Haplobank enables genome-saturated forward screening and validation to discover novel genes underlying specific phenotypes.
PLA2G16 can catalyse the rate-limiting step of arachidonic acid synthesis, and therefore couples to cyclooxygenases (Cox) and prostaglandin synthesis 24, 25 . However, different Cox inhibitory drugs did not block RV-A1a-mediated cell death of control or repaired Pla2g16 sister mES cells, nor did arachidonic acid enhance RV-A1a toxicity (Extended Data Fig. 6a ). Selective survival of Pla2g16-or Ldlr-mutant mES cells was not affected by Cox inhibitors (Extended Data Fig. 6b ). Of note, the Cox inhibitory drugs ibuprofen and indomethacin conferred partial resistance to RV-A1a in HEK293T cells (Extended Data Fig. 7a-c) , albeit at concentrations that also affect other pathways 26 . Structurally, the short C-terminal vesicular domain of PLA2G16 extends into the endosomal lumen where the virion is located before releasing its RNA 27 (Fig. 2f) . To test the relevance of this domain, we edited the Pla2g16-coding region in the endosomal C terminus and 3′ untranslated region (UTR) using CRISPR-Cas9 and selected for RV-A1a-resistant cells. Mutations conferring resistance to RV-A1a were enriched in the transmembrane domain and the vesicular domain ( Fig. 2f and Extended Data Fig. 7d-f ), consistent with a recent, independent haploid screen that identified PLA2G16 in picorna viridae infection 28 . Our results identify the C-terminal domain of Pla2g16 as a target to block rhinoviral infections.
As a third application of the Haplobank, we investigated pathways required for angiogenesis 29 . Multiple candidate angiogenesis genes have been proposed, but few have been functionally validated 30, 31 . We adapted blood vessel sprouting in embryoid bodies, because this recapitulates key features of in vivo angiogenesis 32 , to our haploid mES cells. Sprouts were positive for the endothelial marker CD31 and the basal membrane protein collagen IV, and formed lumens (Fig. 3b ). Similar to in vivo blood-vessel formation, the cells at the periphery of the vascular structures exhibited characteristic features of tip cells, such as CD31-positive filopodia protrusions, followed by stalk cells (Fig. 3b) . Tip cells express delta-like ligand 4 (Dll4), which activates the Notch1 pathway on stalk cells to suppress their conversion into tip cells 33 . We used Notch1 antisense, non-disruptive clones from the Haplobank and, using Cre recombination, created stable sister, sense clones with knockout of Notch1 expression (Extended Data Fig. 8a ). Embryoid bodies were derived from multiple sense, knockout sister clones and displayed significantly increased vessel density (Extended Data Fig. 8b and data not shown). Gene-trap integration upstream of the Notch1 gene did not alter vessel density (Extended Data Fig. 8c) . Therefore, the sprouting assay of embryoid bodies recapitulates normal blood-vessel development.
To identify new genes, we selected candidate genes that were more highly expressed in tip versus stalk cells 30, 31 and were associated with human vascular disease (Extended Data Fig. 8d ). We focused on 32 genes that were represented in the Haplobank. To ensure that differences in angiogenesis are directly linked to inactivation of the respective target genes, and not genetic background noise or clonal effects, we performed colour tracing. We infected selected mES cells with GFP-expressing or mCherry-Cre-expressing retroviruses to generate sister clones with reverted orientation of the integration (Fig. 3c) . We observed large variability between independent clones (Extended Data Fig. 8e, f) , highlighting the importance of comparing a mutant to genetically repaired sister clones for each gene. Genetic inactivation of Myst3 (also known as Kat6a), Mecom, Gja1, Gabrb3, Tnfrsf1a and Dlg2 reduced sprouting angiogenesis and decreased vessel formation at least twofold compared to antisense clones; gene trapping of Enpp3, Smarca1, Ndufs4, Plcb1 or Hck promoted blood vessel growth (Fig. 3d, e and Extended Data Fig. 9) . Therefore, the Haplobank enabled rapid, functional and reproducible validation of candidate angiogenesis genes in engineered blood vessels.
To assess the in vivo role of these angiogenesis genes, we generated embryoid bodies from mES cells stably expressing mCherry and injected + blood vessel sprouts. Data were normalized to the respective antisense sister clones. Data are mean ± s.e.m. from a minimum of n = 3 independent experiments. * P < 0.05, * * P < 0.01, * * * P < 0.001; two-tailed Student's t-test.
them into immunocompromised mice. The resulting teratomas were assessed for mES-cell-derived mCherry +
IB4
+ blood vessels ( Fig. 4a and Extended Data Fig. 10a ). To control for teratoma growth rates, we injected 1:1 mixed mosaic embryoid bodies of sense (mutant, GFP + ) and their respective antisense clones (repaired, mCherry + ). The contribution of GFP-or mCherry-expressing cells to the endothelial lineage and non-endothelial tissues was assessed by cytometry (Extended Data Fig. 10b ). Mutated clones of Myst3, Gja1 and Grin2b showed a decreased contribution to IB4
+ vasculature ( Fig. 4a and Extended Data Fig. 10b ). By contrast, mutant clones that showed increased vessel density in vitro exhibited a greater capacity to form blood vessels in vivo than their antisense sister clones (Fig. 4a) . These data were confirmed using in situ blood-vessel analysis of mixed teratomas (Fig. 4b) . To test whether the identified genes modulate angiogenesis via specification of tip cell fate, we performed mosaic tip cell competition assays (Extended Data Fig. 10c, d ). As a positive control, we assessed genetic modulation of the Notch1 pathway. As expected, mCherry + (sense knockout) Notch1 mutant cells preferentially localized to the tip position compared to GFP + antisense Notch1-expressing sister clones (Fig. 4c, d ). Most clones carrying gene mutations that increased sprouting activity displayed a significant increase to the tip cell position, and vice versa ( Fig. 4c-e) . Therefore, the identified angiogenesis genes can control the tip cell fate.
We tested whether one of our angiogenesis genes, Gja1, which encodes the gap junction α -1 protein (ref. 34), is involved in physiological vascularization of the mouse retina, which begins at birth and progresses until postnatal day 7 (ref. 35). At postnatal day 6, we observed high expression at the angiogenic front where gap junction α -1 protein localized to endothelial junctions, with the highest intensity in tip cells (Extended Data Fig. 10e ). At the vascular plexus, gap junction α -1 protein expression was predominantly detected in perivascular cells, but not in endothelial cells (Extended Data Fig. 10f ). Moreover, gap junction α -1 protein was primarily detected at the tip of the developing vascular sprout in 3D blood vessels (Extended Data Fig. 10g ). Newborn mice injected intravenously with a gap junction α -1 protein-blocking peptide displayed a delay in vascular network progression and complexity in the retina compared to those injected with a scrambled control peptide 36 (Fig. 4f ). The number of tip cells at the angiogenic front was decreased and there were decreased numbers of branch points in the vascular plexus (Fig. 4f) . Therefore, gap junction α -1 protein is a key regulator of tip cell fate and physiological angiogenesis in vivo.
In summary, the Haplobank resource contains over 100,000 individually mutagenized and barcoded mES cell lines targeting 16,970 protein coding genes. The Haplobank complements a collection of 3,396 reversibly targeted genes in a near haploid human leukaemia cell line 37 . Our proof-of-principle experiments uncovering genes that are required for rhinovirus infection and angiogenesis show the power of the Haplobank in forward and reverse genetic screens, respectively. The strong variability between independent clones revealed the importance of assessing mutant and repaired clones side-by-side, and addresses an increased demand for rigor and reproductibility 38 . Therefore, clones from the Haplobank combined with the use of reversible technologies enable high-throughput, reproducible, functional annotation of the genome.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. Data are mean ± s.e.m. of a minimum of n = 3 independent experiments. a, d, * P < 0.05, * * P < 0.01, * * * P < 0.001; two-tailed Student's t-test. e, Representative image of mosaic blood-vessel sprouts from Gja1 sense and antisense sister clones. Scale bars, 500 μ m and 100 μ m (insert). f, Intravenous injection of a Gja1 inhibitory peptide (GAP26) into neonatal mice abrogated retinal angiogenesis. At day 5 after birth, retinas were isolated and stained for IB4 + blood vessels. Scale bars, 500 μ m (top) and 100 μ m (bottom).
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MethOdS
Haploid mES cell cultures. The haploid mES cells used for this study are a feeder-independent clonal derivative of HMSc2 termed AN3-12. Haploid mES cells were grown in standard ES cell medium with serum and LIF. Cell-culture-grade dishes were from Greiner (15-cm Cellstar cell culture dishes, 639160) and NUNC (all other formats, for example, 10-cm dish Nunclon ∆ Surface, 150350; six-well Nunclon ∆ Surface, 140675). The following ES cell medium (ESCM) was used: 450 ml DMEM (Sigma-Aldrich, D1152), 75 ml FCS (Invitrogen), 5.5 ml penicillinstreptomycin (Sigma-Aldrich, P0781), 5.5 ml NEAA (Sigma-Aldrich, M7145), 5.5 ml l-glutamine (Sigma-Aldrich, G7513), 5.5 ml NaPyr (Sigma-Aldrich, S8636), 0.55 ml β ME (Merck, 805740, 10 μ l bME was diluted in 2.85 ml PBS for a 1,000× stock) and ESGRO (Millipore ESG1107; used according to the manufacturer's instructions). For freezing, mES cell clones were expanded, collected from a confluent 10-cm dish by trypsinization, the reaction stopped with ESCM, and subsequently the cells were centrifuged at 1,200 r.p.m. for 5 min. Supernatants were discarded and cell pellets resuspended in 1 ml PBS. Subsequently, 20 μ l of the cell suspension was removed and used to prepare DNA for barcode and integration site PCR. Finally, 7 ml freezing medium was added (one volume ESCM, one volume FCS, 11% DMSO (Sigma-Aldrich, 41648)) and cells were frozen in quadruplicates in two-ml cryovials. Enzymatic mycoplasma tests were performed on a weekly basis. For purification and maintenance, haploid cells were trypsinized and incubated in 10 μ g ml −1 Hoechst33342 (Sigma-Aldrich, B2261) for 30-40 min at 37 °C and analysed by FACS sorting using a BD AriaIII equipped with a near-UV laser. For flow cytometric analysis cells were trypsinized and analysed using a FACS BD LSRFortessa (BDBiosciences) equipped with a high-throughput sampler. Data analysis was performed using FACS Diva and FlowJo. To generate singlecell-derived colonies, 200 cells per 10-cm dish were plated and grown for 10-11 days. Cells were washed once with PBS, and clones were manually picked in 20 μ l PBS under a binocular into 96U-well plates (NUNC). The picked colonies were dispersed into single cells by incubation with 5 μ l 0.25% trypsin in 20 μ l PBS for 6 min at 37 °C. The reaction was stopped with 175 μ l ESCM, and the cells were then split into 96F-well plates, or directly into a 24-well dish for further analysis. For robot-assisted picking, colonies were manually transferred in 20 μ l PBS or DMEM into U-well plates. After picking, cells were dissociated in a Hamilton Laboratory Star using trypsin as above and plated in 5 replicas using the 96-head pipetting block. Clones were expanded in 96-well plates for three days and frozen in matrix plates with 2D barcodes or in cryogenic vials (Thermo Scientific) and transferred into liquid nitrogen. A step-by-step protocol describing haploid cell culture can be found in ref. 39 . Viral and transposon vectors for haploid mES cell mutagenesis. For retro-and lentiviral library generation, gene-trap viruses carrying a neomycin-resistance cassette were packaged in PlatinumE (Cell Biolabs, used only at early passage after obtaining from vendor, tested for cell identity by antibiotics resistance and capability to package virus) or LentiX (Clontech, used only at early passage after obtaining from vendor, further identified by capability to package virus) cells, respectively. For some experiments, virus was concentrated by centrifugation (25,000 r.p.m., 4 °C, 4 h) and FACS-sorted haploid mES cells were then infected for 8 h in the presence of 2 μ g polybrene per ml; 50 μ M JQ1 was used to increase infection efficiency. For transposon-based library generation, FACS-sorted haploid mES cells were nucleofected (Amaxa Nucleofector, program A13) using transposons-containing gene-trap cassettes carrying a splice acceptor, a RPB1 promoter and a neomycin-resistance gene. After infection for 30 h, selection for gene-trap insertions was carried out using G418 (Gibco) at 0.2 mg ml −1
. To estimate the numbers of integrations and therefore library complexity, 10,000 cells (for viruses) or 50,000 cells (for transposons) were plated on 15-cm dishes and selected using G418. For comparison, 1,000 cells were plated but not exposed to G418 selection. On day 10, colonies were counted. 4D pooling. In brief, up to one-hundred 96-well plates containing lysed cells were stacked into 10 towers of 10 plates (that is, slices). In the first step, lysates were pooled into master tower plates containing pools of all plates within one tower and a fraction of lysate was separated into jars containing pools of all wells of each plate termed slice. While processing further towers, identical slices were united with previous ones and new master tower plates were generated. In a second run, master tower plates were pooled along rows and columns of 96-well plates representing all wells within one tower. Finally, this resulted in 40 pools representative of 12 columns, 8 rows, 10 slices and 10 towers. Lysates of each well were thus present in four coordinates. Upon DNA purification, the 40 individual pools were processed for inverse PCR (iPCR) adding individual indices to each pool in the PCR step. Subsequently, the pool of all coordinates was sequenced within one lane of an Illumina sequencer. Two independent strategies of iPCR based on different restriction enzymes were used to identify mutations and coordinates. In addition, direct genomic PCR amplifying the internal barcodes of the mutagens was performed with the same experimental indices. For details see below.
Parallel cloning of internal barcodes. All mutagenesis vectors were designed with highly complex barcodes for confirmation of the generated clones. The complex barcode sequences were obtained as ultramers from Integrated DNA Technologies as PAGE Ultramer DNA Oligos and contained 32-bp barcode sequences flanked by BspEI and BstEII restriction sites. Two versions with either strong-weak or weak-strong alternating sequences were cloned into each frame; barcode sequences were amplified by PCR and purified over columns (Qiagen). The gene-trap vector plasmids (GT-MCS, frame 0/1/2) were digested with AgeI and BstEII and dephosphorylated. Fragments were separated by agarose gel electrophoresis, phenol extracted and precipitated with ethanol. Amplified barcode oligos were digested with BspEI and BstEII. Backbones and inserts were ligated with T4 DNA ligase (NEB) and electroporated (BioRad, Gene Pulser II) into appropriate electrocompetent cells. Bacteria were plated and grown overnight and further expanded in liquid culture for 6 h. Plasmid DNA extraction was performed using established protocols (Qiagen). The following barcode PCR primers were used: forward, GTTGATCTGAGCTACTCATCAACGGT; reverse, AAGTTCCTTCTGGTTCTGGCTCTGCT. For each PCR reaction, 20 μ l was analysed on a 2% agarose gel and PCR products were purified for sequencing using Illustra ExoStar 1-step kit (GE Healthcare). For Sanger sequencing, the barcode PCR-reverse primer was used. Mapping of genomic integrations by next-generation sequencing. Enzyme 1 (E1) was used to fragment the genome. Because the recognition sequence for E1 is also present adjacent to the barcode of the gene-trap vector, it is possible to retrieve the exact integration site of the gene-trap cassette within the genome by circularizing E1-digested genomic DNA (gDNA) and subsequent amplification of the genomic region by iPCR using primers 'US' and 'DS' . To improve iPCR efficiency, a linearization step using E2 was introduced, which re-opens the rings generated previously. Two mapping strategies using enzymes E1 were implemented for each mutagenesis system. For protocol details and sequence information, please also see https://www.haplobank.at/. For retroviruses, E1 were NlaIII, MseI; E2 was SbfI; and the mapping strategy was 5′ . For Tol2, E1 were NlaIII, TaqI; E2 was PacI; and the mapping strategy was 3′ . For lentiviruses, E1 were NlaIII, TaqI; E2 was PacI; and the mapping strategy was 5′ . The following illumina iPCR primer sequences were used: D S, A AT GA TA CG GC GA CC AC CG AG AT CT AC AC GA GC CA GA ACCAGAAGG AACTTGAC; U S , CAAGCAGAAGACGGCATACGAGATINDEXGTGACTGG AGTTCAGACGTGTGCTCTTC; INDEX indicates the custom barcode of 4-8 bp.
For genomic DNA preparation, cell pellets were lysed in lysis buffer (10 mM Tris-HCl pH 8.0, 5 mM EDTA, 100 mM NaCl, 1% SDS, 1 mg ml −1 proteinase K) and incubated at 55 °C overnight. RNase A (Qiagen, 100 mg ml −1 ) was added at a ratio of 1:1,000. After incubation for 1 h at 37 °C, two phenol:chloroform: isoamyl alcohol extractions and a chloroform:isoamyl alcohol extraction, using phase-lock tubes (5Prime), were performed. Samples were then incubated overnight at the digestion-enzyme-specific temperatures. Restriction digests were purified using a PCR Purification Kit (Qiagen) and ring-ligated using T4 DNA ligase (Roche Applied Science). The ring-ligation reaction was incubated overnight at 16 °C, heat-inactivated at 65 °C for 15 min and linearized by adding 1 μ l E2 for 2 h at 37 °C. The digest was again purified using a PCR Purification Kit (Qiagen). The eluate was then used for iPCR. A 20 μ l sample was analysed on an agarose gel and the remaining PCR products were purified using a Gel Extraction Kit (Qiagen). Next-generation sequencing (NGS) was performed on an Illumina HiSeq2500 sequencer according to the manufacturers' protocols. Sequencing primers used for the first read as well as the experimental indices in barcode-PCR were custom-made, other primers were standard Illumina primers: retrovirus 1:1 mix (owing to alternative processing of viral long terminal repeats (LTRs)), GAGTGATTGACTACCCGTCAGCGGGGGTCTTTCA and TGAGTG ATTGACTACCCACGACGGGGGTCTTTCA; Tol2, CACTTGAGTAAAATTTT TGAGTACTTTTTACACCTCTG; lentivirus, CAGACCCTTTTAGTCAGTG TGGAAAATCTCTAGCA.
To additionally confirm the genomic integration site of the gene-trap cassettes, gene-specific primers flanking the mapped locus were paired with mutagen-specific primers to confirm integration and the absence of the wild-type allele. Integration-site-specific primers were designed using Clone Manager 9 software (Sci-Ed Software). For each integration site, four PCR reactions with respective primer combinations (integration-site-specific forward and reverse primer and integration-site-specific forward or reverse with mutagen-specific forward or reverse primer) were performed. The following mutagen specific primers were used: retrovirus-INT-fwd, CCAGAACCAGAAGGAACTTGC; retrovirus-INT-rev, TACAGACGCAGGCGCATAACAC; lentivirus-INT-fwd, GCCAGAACC AGAAGGAACTTGC; lentivirus-INT-rev, AGAGCTCCTCTGGTTTCCCTTTC; Tol2-INT-fwd, GAGCCAGAACCAGAAGGAACTG; Tol2-INT-rev, CCGGGC AATGGATTGATATTGG. 4D deconvolution of NGS reads. On the basis of the restriction enzyme used for genome digestion, the first read was cut at the first restriction site if it was present Letter reSeArCH within 50 bp of the mapped sequence. A minimal length of 15 nt was required. The sequence was aligned with Bowtie against the mm10 genome 40 . A maximum of 1 mismatch (-v 1) was allowed. Only unique alignments (-m 1) in the best strata are reported. The second read reading out the internal barcode was trimmed after 32 nt. The alignment/internal barcode pairs were assigned to a defined well via the experimental indices. A valid assignment required a minimal count of three per coordinate and a minimal fraction of 0.75 over alternative coordinates. The internal barcodes were merged with 4D pooling data if its count was higher than 20. This strategy was also used to verify the existing coordinates and uncover missing coordinates and/or additional integrations. Mapped insertions were intersected with the annotation (Ensembl) of all gene features, including the intergenic region using BEDtools 41 . In silico insertions were randomly sampled from the mouse genome and aligned back to the genome. Chromosome spreads and FISH. Metaphase chromosomes were collected according to standard protocols. For multiplex-fluorescence in situ hybridization (M-FISH), a mouse 21-colour painting probe was generated following the pooling strategy 2 . The M-FISH probe was denatured at 65 °C for 10 min before being applied onto the denatured slides. The hybridization area was sealed with a 22 × 22-mm coverslip and rubber cement. Hybridization was carried out in a 37 °C incubator over two nights. The post-hybridization washes included a 5-min stringent wash in 0.5× SSC at 75 °C, followed by a 5-min rinse in 2× SSC containing 0.05% Tween20 (VWR) and a 2-min rinse in 1× PBS, both at room temperature. Finally, slides were mounted with SlowFade Gold mounting solution containing 4′ 6-diamidino-2-phenylindole (DAPI, Invitrogen). Images were visualized on a Zeiss AxioImager D1 fluorescent microscope equipped with narrow band-pass filters for DAPI, DEAC, FITC, CY3, Texas red and CY5 fluorescence and an ORCA-EA CCD camera (Hamamatsu). M-FISH digital images were captured using the SmartCapture software (Digital Scientific UK) and processed using the SmartType Karyotyper software (Digital Scientific UK). Approximately 200 metaphases from AN3-12 were counted for the diploid versus haploid frequency and 10 well-spread metaphases were fully karyotyped by M-FISH and DAPIbanding pattern 42 .
Copy number variation (CNV) analysis.
Discriminative coverage analysis was performed to identify differences between genotypes in the number of copies of a genomic region as previously described (PMID: 22136931). In brief, reads from 129, AN312 and C57BL/6J samples were aligned against the mm10 C57BL/6J mouse reference genome using Bowtie v.1.2 with parameters -v 3 -m 1-beststrata. Coverage in non-overlapping 10-kb windows over the whole genome was calculated using Bedtools (v.2.26.0) makewindows and multicov (PMID: 20110278). Read counts were scaled by library size and for each sample windows and extreme outlier counts were removed. SNP mapping. Variants were called with GATK v.3.7-0 (PMID: 20644199) following established best practices. In brief, reads were aligned to the mm10 C57BL/6J mouse reference genome using BWA mem (BWA v.0.7.12), duplicate reads were marked using Picard v.2.6.0, reads were locally realigned around indels, base quality recalibration was performed using mm10 dbSNP as a training set, variants were called using HaplotypeCaller with ploidy set to one for AN312 and two for C57BL/6J and 129 samples, and variant filtration was applied according to GATK guidelines. For each sample, homozygous SNPs were counted in nonoverlapping 10-kb sliding windows and counts were plotted to estimate the distribution SNP densities on the mm10 reference genome. RNA sequencing. Reads were screened for ribosomal RNA by aligning with BWA (v.0.6.1) 43 against known rRNA sequences (RefSeq). The rRNA-subtracted reads were aligned with TopHat (v.1.4.1) 44 against the Mus musculus genome (mm10); a maximum of six mismatches were allowed. Maximum multihits were set to 1 and InDels as well as Microexon-search was enabled. Additionally, a gene model was provided as GTF (UCSC RefSeq mm10). rRNA loci were masked on the genome for downstream analysis. Aligned reads were subjected to FPKM measurements with Cufflinks (v.1.3.0) 37, 45 . Furthermore, only those fragments compatible with UCSC RefSeq annotation (mm10) of genes with at least one protein-coding transcript were allowed and counted towards the number of mapped hits used in the FPKM denominator. The mean FPKM was calculated over the replicates. Chromatin immunoprecipitation. ChIP was essentially performed as described previously 46 . In brief, after trypsinization, 25 million haploid mES cells were washed once in PBS before fixation for 7 min at room temperature by addition of formaldehyde to a final concentration of 1%. Crosslinking was quenched by addition of 2.5 M glycine (0.125 M final concentration) and cells were then incubated on ice. Crosslinked cells were spun at 600g for 5 min and nuclei prepared by consecutive washes with rinse 1 buffer (final: 50 mM HEPES pH 8.0, 140 mM NaCl, 10% glycerol, 0.5% NP40, 0.25% Triton X-100, 1 mM EDTA) followed by rinse 2 buffer (final: 10 mM Tris pH 8.0, 1 mM EDTA, 0.5 mM EGTA, 200 mM NaCl). Nuclei were resuspended in 2 ml total volume of sonication buffer (0.1% SDS, 1 mM EDTA pH 8, 10 mM Tris HCl, pH 8 with protease inhibitor complete mini (Roche)) and then sonicated with a Covaris E22 sonicator (Covaris settings: 5% duty cycle, PIP 140, 200 cyles per burst, 15 min). ChIP was performed at 4 °C in ChIP buffer (final: 50 mM HEPES/KOH pH 7.5, 300 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% DOC, 0.1% SDS) with the indicated antibody. Precipitated chromatin was purified using Dynabeads Protein G (Thermofisher, 10003D). ATAC-seq. ATAC-seq was performed as reported previously 47 . In brief, 50,000 cells were washed in cold PBS before gentle resuspension in 50 μ l of cold lysis buffer (10 mM Tris-HCl pH 7.4, 10 mM NaCl, 3 mM MgCl 2 , 0.1% Igepal CA-630). For the transposition reaction, nuclei were collected by immediate centrifugation for 15 min at 4 °C. The supernatant was removed and nuclei were suspended in 50 μ l of transposition reaction mixture (25 μ l 2× TD buffer (Nextera kit), 2.5 μ l TDE1 (Nextera Tn5 Transposes), 22.5 μ l nuclease-free water). The transposition reaction was performed at 37 °C for 30 min followed by DNA purification using the Qiagen MinElute Kit. 5′ RACE. TRIzol was used to isolate 10 μ g of total RNA from mES cells (ThermoFisher Scientific), followed by additional purification and DNase treatment with the Qiagen RNeasy mini kit. PolyA mRNA was enriched using dT(25)-Dynabeads (ThermoFisher Scientific) using the manufacturers' recommendations. Purified mRNA was reverse transcribed with SuperScript II polymerase (Invitrogen) in the presence of random hexamer primers using the following incubation protocol: 25 °C for 10 min, 42 °C for 50 min, 50 °C for 10 min, 70 °C for 15 min. cDNA from the reaction was purified with the MinElute reaction clean-up kit (Qiagen) and tailed with dCTPs using Terminal Transferase (NEB). One-tenth of the reaction was used for the first round of PCR with dG-anchor-primer/g.s.-outer-primer: 96 °C for 2 min, 23 rounds of (96 °C for 15 s; 60 °C for 15 s; 68 °C for 3 min), 72 °C for 10 min. Reaction products were diluted 10× and used for the second round of PCR with dG-sec-anchor-primer/g.s.-inner-primer with the following incubation protocol: 96 °C for 2 min, 23 rounds of (96 °C for 15 s; 63 °C for 15 s; 72 °C for 3 min), 72 °C for 10 min. Reaction products were purified with the MinElute clean-up kit and cloned into a pJet1.2 vector (ThermoFisher Scientific). Bacterial colonies were picked and sequenced with β -geo_R4 primer. The following primers were used: g.s.-inner-primer, GTATCGGCCTCAGGAAGATCG; g.s.-outer-primer, GCATCGTAACCGTGCATCTG; dG-anchor-primer, CTACTACTACTAGGCCACGCGTCGACTAGTACGGGGGGGGGG; dG-secachor-primer, CTACTACTACTAGGCCACGCGTCGACTAGTAC; β -geo_R4, TCAGGCTGCGCAACTGTTGG. Differentiation of parthenogenetic mES cell clones. mES cells were dissociated using trypsin and embryoid body formation was induced using the hanging drop technique (1,000 cells per 20 μ l drop) in ESCM without LIF. After three days, the embryoid bodies were collected and transferred to untreated Petri dishes for further differentiation. On day 5 and day 12, embryoid bodies were collected and RNA was isolated using TRIzol (Invitrogen) according to the manufacturers' protocol. Subsequently, 1 μ g RNA was reverse transcribed into cDNA using the iScript cDNA Synthesis Kit (Bio-Rad) and qRT-PCR was performed with the GoTaq qPCR Master Mix (Promega, A6001) using a Bio-Rad CFX384 Connect Real-Time PCR Detection System. The following primers (5′ to 3′ ) were used for qRT-PCR: Oct4, fwd CCTACAGCAGATCACTCACATCGCC, rev CCTGTAGCCTCATACTCTTCTCGTTGG; Klf4, fwd GTGCCCCGACTA ACCGTTG, rev GTCGTTGAACTCCTCGGTCT; Nanog, fwd CAGGAGTTTGA GGGTAGCTC, rev CGGTTCATCATGGTACAGTC; keratin 18, fwd TTGCCGCC GATGACTTTAGA, rev GGATGTCGCTCTCCACAGAC; Nkx2-5, fwd CCCAAG TGCTCTCCTGCTTT, rev TTTTTATCCGCCCGAGGGTC; Sox17, fwd GAATCC AACCAGCCCACTGA, rev TAGGGAAGACCCATCTCGGG.
To assess protein expression of pluripotency genes during differentiation, the haploid mES cells were cultured in ESCM without LIF in the presence of 500 nM all-trans-retinoic acid (Sigma-Aldrich, R2625) and the medium was replaced every other day. At indicated time points the cells were fixed in 4% PFA and stained using antibodies against Oct4 (BD Bioscience, 611202), Nanog (R&D Systems, AF2729) and Sox2 (R&D Systems, AF2018), counterstained with DAPI and imaged with a Zeiss LSM 780. DNA content analysis and growth curves. Haploid AN3-12 cells were routinely passaged and fixed at indicated time points in ice-cold 85% ethanol and stored at − 20 °C. For analysis of DNA content, cells were stained with 10 μ g ml
Hoechst33342 (Sigma-Aldrich, B2261) for 30 min on ice, washed and analysed on a BD Fortessa. Viable cells were counted using a Countess II FL (ThermoFisher Scientific) according to the manufacturer's protocol. Keratinocyte differentiation. Embryoid bodies from 2,000 cells were generated using the hanging drop technique. After three days, 30-50 embryoid bodies were transferred to an ultra-low-attachment six-well plate and stimulated with 1 μ M retinoic acid for three more days. Next, embryoid bodies were transferred onto Letter reSeArCH collagen-IV-coated dishes in ESCM without LIF medium supplemented with 25 ng ml −1 hBMP-4 (R&D Systems). After three more days, the cells were incubated with CnT-07 keratinocyte medium (CELLnTEC) and cultured for six more days. The keratin14-positive cell population was enriched by using the rapid adherence to Collagen IV: trypsinized cells (0.25% trypsin-EDTA) were plated onto Collagen-IV-coated wells and non-adherent cells were washed off after a 15-min incubation at room temperature. Reversion of gene-trap cassettes. To reverse gene-trap cassettes, mES cells were either stably infected or transiently transfected with a Cre-or Flpo-expressing plasmid also containing a fluorescent marker, for example, eGFP or DsRed, using Lipofectamine 2000 (Invitrogen), Amaxa nucleofector (program A-13) or viral delivery as outlined above. If single-cell-derived clones were needed, cells were FACS-sorted for mCherry + or GFP + cells 24-48 h after lipofection/nucleofection and 1,000 cells were then seeded on 15-cm tissue culture dishes. On day 10 after sorting, colonies were picked and used for further analysis. For stable integration of Cre and the colour marker upon infection, PlatinumE cells (Cell Biolabs) were transfected with the respective plasmids and mES cells were subsequently infected. After 30 h of infection, cells were puromycin selected for a further 72 h. As controls, GFP-puro-infected cells were selected and used. Inversion of the splice acceptor was determined by PCR on genomic DNA. The PCR was performed with three primers on mES cell lysates. Dependent on the orientation, either a fragment binding the first forward primer or a fragment binding the inverse forward primer were amplified. Upon first inversion, PCR fragments are larger in length. The second inversion results in a size reduction below the original orientation. The following specific PCR primers were used for Retro-, Lenti-, Tol2-EGT: EGT first fwd, CGACCTCGAGTACCACCACACT; EGT inv fwd, AAACGACGG GATCCGCCATGTCA; EGT com rev, TATCCAGCCCTCACTCCTTCTCT. Expected bands for Retro-, Lenti-, Tol2-EGT are: EGT first fwd/EGT com rev: 343 bp; EGT inv fwd/EGT com rev: 443 bp. The PCR primers for Tol2-pA were: Tol2 first fwd, TGGGTTCAAGCGATTCTCCTGCCTCA; Tol2 inv fwd, AGATAGGCACC CAGGGTGATGCAAGCTC; Tol2 com rev, CCGATCCATCCATCGCAT ATTTGGGA. Expected bands for Tol2-pA: polyA trap first fwd/Tol2 com rev: 326 bp; polyA trap inv fwd/Tol2 com rev com rev: 439 bp. RV-A1a infections. For virus production, HeLa cells at a confluency of 70-80%, were washed with PBS and infected with RV-A1a in infection medium (DMEM, 2% heat-inactivated FCS, 1% penicillin-streptomycin, 1% l-glutamine, 30 mM MgCl 2 ). After an incubation for 24 h, the virus was released from the cells by three freeze/thawing cycles and subsequently cellular debris was removed by centrifugation and filtration (4,000 r.p.m. for 10 min at 4 °C). For the genome-wide screen, retrovirally mutagenized haploid mES cells were seeded in 15-cm dishes (1 × 10 7 cells per dish), and 5 h after seeding, cells were infected with RV-A1a at a multiplicity of infection (MOI) of 5 in a 1:1 mixture of HeLa infection medium:ESCM (MgCl 2 and LIF were additionally added to balance the concentrations). For control mock infections, the HeLa infection medium/ESCM mixture was used. On day 21 after infection, cells were pooled and further processed for isolation of genomic DNA or frozen. Validation in mES cells was done using clones from the Haplobank (Ldlr: clone 1 is 238F02, clone 2 is 374A09, clone 3 is 1031A04; Pla2g16: clone 1 is 371H01, clone 2 is 588G11, clone 3 is 917E06). HEK293T cells from an institute resource were tested for neomycin resistance to confirm cell identity. They were infected with GFP, empty guide and Cas9-containing control, or puro-selection marker, guide and Cas9-containing control vectors. Subsequent to selection, CRISPR-Cas9-edited cells were mixed with GFP-positive cells. These cell mixtures were monitored in the presence and absence of RV-A1a for shifts in ratios of GFP-expressing cells using FACS (BD LSRFortessa and FlowJo). Arachidonic acid, acetylsalicylic acid, ibuprofen, indomethacin, diclofenac and celecoxib (all from Sigma-Aldrich) in DMSO were added to the cells 2 h before RV-A1a infection at the indicated concentrations. For interaction studies with Pla2g16 and Ldlr in mES cells, the following drugs were used: 1 mM acetylsalicylic acid, 10 μ M archidonic acid, 910 nM celecoxib, 380 nM Diclofenac, 0.1% DMSO (vehicle), 72 μ M ibuprofen, 10 μ M indomethacin.
The following guide sequences were used for mutagenesis: GFP sg, GAGCTGG ACGGCGACGTAAA; LDLR sg1, TCAGACCGGGACTGCTTGGA; LDLR sg2, CT GTTGCACTGGAAGCTGGC; LDLR sg3, GCTGTTGCACTGGAAGCTGG; LDLR sg4, GGAGCTGTTGCACTGGAAGC; PLA2G16 sg1, GAAGGAATTGCTG TATGATG; PLA2G16 sg2, CCTGCAGCAAAATCATCCAG; PLA2G16 sg3, CTATGTTGGCGATGGATATG; PLA2G16 sg4, CGCTGGATGATTTTGCTGCA; Pla2g16 sgRNA1, TTGCTTCTGTTTCTTGTTTC; Pla2g16 sgRNA2, CTGAATG ACTGCCCAGTTTT. Blood-vessel sprouting assays. mES cells were trypsinized and seeded at 9,600 cells per embryoid body in a 96-well low-attachment plate (Sumitomo Bakelite, Prime Surface-U). After incubation for 14 days in ESCM without LIF in the presence of puromycin, the embryoid bodies were washed in ESCM without LIF, embedded in 3D collagen I gels and stimulated with 50 ng ml −1 VEGFA (in-house production) as previously described 32 . The first vascular outgrowth was observed after around seven days and capillary-like networks were analysed two weeks after initial embedding of the embryoid bodies into the collagen I matrix. For tip cell competition assays, mosaic embryoid bodies were generated from GFPpositive and mCherry-Cre-positive haploid mES cells. In brief, haploid mES cells were infected with viral supernatants collected from Platinum-E cells expressing GFP-Puro or mCherry-Cre-Puro. 48 h after infection the cells were treated with 10 μ g ml −1 puromycin (Invivogen) to select for infected cells. Infected cells were FACS-sorted for the 5% highest GFP/mCherry-expressing cells, constantly kept under puromycin selection pressure to avoid reporter silencing, and then mixed at a 1:1 ratio to generate mosaic embryoid bodies. The following clones from the Haplobank were used to generate blood vessel organoids: Myst3 00235| A10; Myst3 00564| C06; Prkcz 00355| E11; Syt16 00160| B12; Tesc 00279| B08; Gfod1 00284| F11; Enpp3 00455| E06; Enpp3 00584| E08; Enpp3 00535| F07; Grin2b 00335| G12; Grin2b 00858| G05; Plcb1 00362| H01; Plcb1 00367| H09; Ndufs4 00318| D02; Ndufs4 10132| G01; Gja1 00345| A03; Tfpi 00281| H03; F2r 00351| E05; Pcsk6 00200| D09; Abcg2 00385| H12; Prkch 00102| C03; Igfr1 00535| B11; Entpd1 00588| B04; F3 00451| B01; Igf1 00455| D06; Plaur 00582| C11; Hckl 00449| E02; Mapt 00569| D06; Dlg2 00339| A01; Tnfrsf1a 00112| H07; Smarca1 00182| D04; Cdh13 00255| G04; Ets2 00341| E06; Tgfbr2 00583| D04; Gabrb3 00578| B04; Abcb1a 00500| A06; Bag3 00338| G02. Immunofluorescence. To visualize the vascular outgrowths, blood vessels were fixed with 4% PFA for 20 min at room temperature and blocked with 3% FBS, 1% BSA, 0.5% Triton X-100 and 0.5% Tween-20 for 2 h. Biotinylated GSL Isolectin B4 (IB4; Vectorlabs 1201), anti-CD31 (BD Pharmingen AB9498) and anti-collagen IV (Millipore AB765P) were applied overnight at 4 °C. After washing with PBS-T (0.05% Tween-20), the organoids were incubated with streptavidin-Alexa488, antirat-Alexa488 or anti-rabbit-Alexa647 secondary antibodies. Before mounting with DAKO mounting medium and analysis under a stereomicroscope, organoids were stained with 1 μ g ml −1 DAPI solution to image nuclei. A Zeiss LSM 780 was used to image the entire vascular outgrowth of every single organoid using the tilescanning option and recording of z stacks. Confirmation of Notch1 gene-trap flipping by PCR and western blot. DNA of stably infected GFP or mCherry-Cre cells was isolated using phenol:chloroform: isoamyl alcohol (25:24:1) (Sigma-Aldrich) and Phase Lock Gel Heavy tubes (5Prime). The following primer sequences were used for PCR: F1st, CTTCTGAGACGG AAAGAACCAGC; Finv, AAACGACGGGATCCGCCATGTCA; Rev, TATCCAG CCCTCACTCCTTCTCT. The pair F1st+ Rev amplifies a fragment of the original, unflipped gene trap and Finv+ Rev amplifies the Cre-recombined, flipped genetrap fragment. Western blotting was performed using standard protocols. Blotted membranes were blocked in 3% BSA and subsequently incubated with antibodies to detect cleaved Notch1 (CST D3B8) and β -actin (Sigma-Aldrich A5316) overnight. After washing in TBS-T (0.1% Tween-20) and incubating with HRPlinked secondary antibodies, blots were incubated in ECL solution (Pierce) for visualization. Teratoma assays. mES cells were dissociated and resuspended in growth-factorreduced Matrigel (Corning, 356231) and kept on ice. Subsequently, 10 6 cells were injected into both flanks of 8-12-week-old MF1 nu/nu mice. Both female and male mice were used. For generation of a chimaeric vasculature, 2 × 10 6 mES cells were cultured in the presence of puromycin to avoid reporter silencing, in 15-cm Petri dishes and mosaic embryoid bodies (GFP:mCherry 1:1) were generated. After eight days of culture, the embryoid bodies were washed, resuspended in 200 ml growth-factor-reduced Matrigel (BD 356231), and injected subcutaneously into the flanks of immunocompromised MF1 nu/nu mice using a 18G needle. Teratomas were analysed 3-4 weeks after injection. To this end, teratomas were either processed for immunohistochemistry or cells were isolated for FACS analysis. H&E slides were reviewed with a Zeiss Axioskop 2 MOT microscope (Carl Zeiss Microscopy) and subsequently digitized with the Pannoramic Flash III (Adimec-Q-12-A-180Fc camera) automated slide scanner (3D Histech). For immunohistochemistry, teratomas were fixed with 4%PFA overnight and subsequently incubated in 20% sucrose for around 24 h before embedding into OCT and processing the tissue to 60-80-mm thick sections using a cryostat. For visualization, sections were incubated with anti-GFP (Abcam, AB111258), anti-mCherry (Abcam, AB125096) and biotinylated-IB4 (Vectorlabs, 1201) overnight. After washing and incubation with anti-goat-Alexa488, anti-mouse-Alexa555 and streptavidin-Alexa633, respectively, the specimens were imaged using a Zeiss LSM780 microscope. For FACS analysis, teratomas were cut into 1 mm pieces and subjected to enzymatic digestion (collagenase type IV 300 U ml −1 , Worthingon; dispase 0.25 U ml −1 , Gibco; DNase 7.5 μ g ml
, Qiagen). Following a 1-h incubation at 37 °C on a shaker, the cell suspension was pipetted through a 70-μ m cell strainer, washed once with DMEM before centrifugation at 400g for 10 min. Single cells were incubated for Letter reSeArCH 45 min with an anti-mouse VE-Cadherin-APC antibody (eBioscience 17-1441-80) on ice. A 10-min DAPI wash was performed to exclude dead cells from the FACS analysis. All animal studies were approved according to Austrian and EU legislature. Retina analyses. Retinas were collected and prepared from mice as previously described 35 . The gap junction α -1 protein inhibitory peptide (GAP26, VCYDKSF PISHVR) and the scrambled control peptide (sGAP26, YSIVCKPHVFDRS) were synthesized by PSL GmbH) and injected intravenously in neonatal C57BL/6 mice as previously described 36,48 at 2 μ g per mouse. Whole-mount retinas were immunostained for IB4 (Vectorlabs, 1201) or gap junction α -1 protein (Abcam, AB11370) expression, incubated with the appropriate secondary antibodies (see above) and imaged using a LSM 780 microscope. Statistics. All values are mean ± s.e.m. or mean ± s.d. Comparisons between groups were made by Student's t-test or two-way ANOVA using GraphPad Prism (GraphPad Software) or R statistical software. No statistical methods were used to predetermine sample size. The experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment. P < 0.05 was accepted as statistically significant. Data availability. All genomic data have been deposited in the NCBI Gene Expression Omnibus and are accessible through GEO accession number GSE84090. All material, protocols and cell lines can be obtained from the website https://www.haplobank.at/ as well as via the Protocol Exchange 
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Extended Data Figure 3 | Molecular characterization of mutagenesis vectors. a, Schematic illustration of the universal NGS strategy. Optimized primer-binding sites compatible with Illumina sequencing and two restriction enzymes with four base-pair recognition sites were placed adjacent to the terminal elements (LTR, TR). An internal barcode of 32 bases with alternating weak and strong bases was inserted in a parallel cloning step. b, For mapping of integration sites, genomic DNA was amplified by iPCR to introduce adaptor sequences and the experimental index for NGS. Paired-end sequencing maps the genomic integration in the first read using a custom primer, the experimental index as well as the internal barcode using standard Illumina primers binding to the integrated complementary sequence. Barcode (BC) PCR was performed on genomic DNA. c, Meta-analysis of mutagen integrations around transcriptional start sites (TSS) (excluding the precise TSS site). In particular Tol2 and retrovirus show a preference to integrate in proximity to the TSS. Retroviruses also frequently integrate into the promotor regions, whereas lentiviral integrations are typically located within the entire gene body. IPKM, insertions per kilobase per million. The vectors used are described in the legend of Fig. 1. d , Distribution of integration sites. Binning the number of integrations in genic and 2-kb upstream regions per 10-kb windows illustrates pronounced cold spots of mutagenesis using retroviral mutagenesis, where one can observe bins devoid of integrations. e, Genomic region surrounding the Gapdh locus exemplifying the distributions of integrations. While retroviral integrations strongly cluster, Tol2 displays a more uniform distribution of integration sites. Tracks are + strand (top) and − strand (bottom) integration sites. Bar lengths indicate NGS read numbers, subsequent to iPCR. f, Heat map illustrating overlap of epigenetic histone marks with integrations of the indicated mutagens, normalized to peak size. Only retrovirus and Tol2 integrations strongly correlate with DNA accessibility determined by ATAC-seq and active marks such as H3K4me3 and H3K27ac. In silico mutagenesis is shown as a control.
Extended Data Figure 10 | Generation of a chimaeric vasculature in vivo  and gap junction α-1 protein localization to tip cells. a, Representative fluorescence image of a haploid mES-cell-derived teratoma stained for endothelial cell-specific IB4. Endothelial cells arising from haploid mES cells are positive for mCherry and IB4 (yellow), whereas host endothelial cells are only positive for IB4 and appear green. Scale bars, 50 μ m. b, Representative FACS analysis of teratomas following injection of chimaeric embryoid bodies into immunocompromised mice. Myst3 antisense (mCherry + ) and sense (GFP + ) sister clones were mixed at a 1:1 ratio. VE-cadherin-negative non-endothelial cells were also determined within the teratomas. c, Parental haploid mES cells stably expressing GFP or mCherry-Cre were assessed for their ability to generate IB4 + vascular structures in the presence of VEGFA. The number and ratios of IB4 + vessels per organoid were not apparently different between GFPexpressing and mCherry-Cre-expressing cells. Scale bars, 500 μ m. Data are shown as mean ± s.e.m. and individual data points from n = 4 independent experiments. P = 0.207; two-tailed Student's t-test. d, GFP-expressing and mCherry-Cre-expressing parental haploid mES cells contribute equally to tip cells (49.2% GFP + ; 50.8% mCherry-Cre + ) in 1:1 mixed mosaic cultures. Data are shown as mean ± s.e.m. and individual data points from of n = 4 independent experiments. P = 0.823; two-tailed Student's t-test. e, Localization of gap junction α -1 protein in the mouse retina at postnatal day 6 (P6). Endothelial cells are marked by IB4 staining. At the angiogenic front, gap junction α -1 protein expression is found in endothelial cells, primarily localized at tip cells (arrows). Scale bars, 50 μ m. f, Retinas were stained for gap junction α -1 protein expression and the endothelial marker IB4 to visualize the vascular networks on P6. Note the punctate pattern of gap junction α -1 protein adjacent to the IB4 + vessels, suggestive of gap junction α -1 protein expression in perivascular cells. Scale 
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